Updated:
Sirona Capital
Sirona Capital is a specialist alternative funds manager focused on urban renewal, private real estate, and agriculture. The firm has made 16 investments,...
Overview
Sirona Capital is a specialist alternative funds manager focused on urban renewal, private real estate, and agriculture. The firm has made 16 investments, including a Series B investment in Kailera Therapeutics on October 14, 2025. Sirona Capital has facilitated 8 portfolio exits, with the most recent being ArriVent Biopharma on January 26, 2024.
General information
Location
Region
North America
Country
United States
City
Pasadena, Chicago, Cambridge, Perth, Doha, Minneapolis, Juneau
Corporate office
Pasadena, Chicago, Cambridge, Perth, Doha, Minneapolis, Juneau, United States
Frequently asked questions
Does Sirona Capital manage wealth for a family?
No source identifies any family or individual whose wealth is managed by Sirona Capital. The firm's public footprint is limited to Sirona Medical’s operations in healthcare IT. Wealth origin and family office structure are not disclosed.
What sectors or stages does Sirona Capital target?
No sector focus, investment stage, or geographic preference is publicly disclosed for Sirona Capital. The available website pertains to radiology software, not capital allocation.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: